Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors-Reference-Cited by-同舟云学术

Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors

Published:2015-05 Issue:5 Volume:26 Page:838-847
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Serpico D.,Trama A.,Haspinger E.R.,Agustoni F.,Botta L.,Berardi R.,Palmieri G.,Zucali P.,Gallucci R.,Broggini M.,Gatta G.,Pastorino U.,Pelosi G.,de Braud F.,Garassino M.C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/5/838/10767251/mdu527.pdf

Reference86 articles.

1. Rare thoracic cancers, including peritoneum mesotelioma;Siesling;Eur J Cancer,2012

2. Rare cancers are not so rare: the burden of rare cancers in Europe;Gatta;Eur J Cancer,2011

3. Epidemiology of thymoma and associated malignancies;Engels;J Thorac Oncol,2010

4. Thymoma. A population-based study of the management and outcomes for the province of British Columbia;Mariano;J Thorac Oncol,2013

5. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy;de Jong;Eur J Cancer,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671);Annals of Oncology;2024-09

2. Penpulimab combined with anlotinib in patients with R/M HNSCC after failure of platinum-based chemotherapy: a single-arm, multicenter, phase Ⅱ study;ESMO Open;2023-12

3. Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies;Journal of Experimental & Clinical Cancer Research;2022-12-14

4. Image Guided Fine Needle Aspiration Cytology of Thymic Lesions: A Four-Year Study;The Indian Journal of Chest Diseases and Allied Sciences;2022-11-18

5. Tropomyosin-related Kinase B Is Potentially a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors;Anticancer Research;2022-07-26